Maravai Lifesciences Holdings (MRVI) Other Operating Expenses (2020 - 2025)

Maravai Lifesciences Holdings' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $25.8 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 128.9% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $96.1 million (down 55.34% YoY), while the FY2025 annual figure was $68.9 million, down 58.02% from the prior year.
• Other Operating Expenses was $25.8 million for Q4 2025 at Maravai Lifesciences Holdings, up from $60000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $154.1 million in Q3 2024 to a low of -$117.0 million in Q4 2023.
• Historically, Other Operating Expenses has averaged $29.2 million across 5 years, with a median of $33.7 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Other Operating Expenses soared 1197.2% in 2021, then tumbled 99.96% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $11.2 million in 2021, then soared by 163.99% to $29.7 million in 2022, then tumbled by 493.96% to -$117.0 million in 2023, then surged by 109.64% to $11.3 million in 2024, then jumped by 128.9% to $25.8 million in 2025.
• The last three Other Operating Expenses figures came in at $25.8 million (Q4 2025), $60000.0 (Q3 2025), and $70.2 million (Q2 2025), per Business Quant data.